Quels risques psychologiques sont associés à un faible tryptophane ?
Un faible niveau de tryptophane peut augmenter le risque de dépression et d'anxiété.
DépressionAnxiétéTryptophane
#5
Le tryptophane peut-il affecter la santé cardiovasculaire ?
Des niveaux déséquilibrés de tryptophane peuvent influencer la santé cardiovasculaire.
Santé cardiovasculaireTryptophaneAcides aminés
Facteurs de risque
5
#1
Quels facteurs augmentent le risque de carence en tryptophane ?
Les régimes pauvres en protéines, le stress et certaines maladies peuvent augmenter le risque.
Facteurs de risqueCarence en acides aminésStress
#2
Les personnes âgées sont-elles à risque pour le tryptophane ?
Oui, les personnes âgées peuvent avoir un risque accru de carence en raison de l'alimentation.
Personnes âgéesCarenceNutrition
#3
Le stress chronique influence-t-il le tryptophane ?
Oui, le stress chronique peut diminuer les niveaux de tryptophane dans le corps.
Stress chroniqueTryptophanePhysiologie
#4
Les troubles alimentaires affectent-ils le tryptophane ?
Oui, les troubles alimentaires peuvent entraîner une carence en tryptophane.
Troubles alimentairesTryptophaneCarence
#5
Les régimes végétaliens présentent-ils un risque pour le tryptophane ?
Oui, les régimes végétaliens peuvent manquer de sources adéquates de tryptophane.
Régime végétalienTryptophaneCarence
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tryptophane : Questions médicales les plus fréquentes",
"headline": "Tryptophane : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tryptophane : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-11",
"dateModified": "2025-03-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tryptophane"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Acides aminés essentiels",
"url": "https://questionsmedicales.fr/mesh/D000601",
"about": {
"@type": "MedicalCondition",
"name": "Acides aminés essentiels",
"code": {
"@type": "MedicalCode",
"code": "D000601",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.125.142"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Tryptophane",
"alternateName": "Tryptophan",
"code": {
"@type": "MedicalCode",
"code": "D014364",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kulmira Nurgali",
"url": "https://questionsmedicales.fr/author/Kulmira%20Nurgali",
"affiliation": {
"@type": "Organization",
"name": "Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia."
}
},
{
"@type": "Person",
"name": "Harry B Gray",
"url": "https://questionsmedicales.fr/author/Harry%20B%20Gray",
"affiliation": {
"@type": "Organization",
"name": "Beckman Institute, California Institute of Technology, Pasadena, California 91125, United States."
}
},
{
"@type": "Person",
"name": "Majid Davidson",
"url": "https://questionsmedicales.fr/author/Majid%20Davidson",
"affiliation": {
"@type": "Organization",
"name": "Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia."
}
},
{
"@type": "Person",
"name": "Vasso Apostolopoulos",
"url": "https://questionsmedicales.fr/author/Vasso%20Apostolopoulos",
"affiliation": {
"@type": "Organization",
"name": "Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia."
}
},
{
"@type": "Person",
"name": "Filip Šebesta",
"url": "https://questionsmedicales.fr/author/Filip%20%C5%A0ebesta",
"affiliation": {
"@type": "Organization",
"name": "J. Heyrovský Institute of Physical Chemistry, Czech Academy of Sciences, Dolejškova 3, CZ-182 23 Prague, Czech Republic."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Impact of Receipt of Information on Prostate-Specific Antigen Testing on Screening with the Prostate-Specific Antigen Test.",
"datePublished": "2023-01-18",
"url": "https://questionsmedicales.fr/article/36652189",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s13187-023-02264-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostate-Specific Antigen Screening in Transgender Patients.",
"datePublished": "2022-11-04",
"url": "https://questionsmedicales.fr/article/36344317",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.eururo.2022.09.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy.",
"datePublished": "2022-07-21",
"url": "https://questionsmedicales.fr/article/35860909",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/pros.24414"
}
},
{
"@type": "ScholarlyArticle",
"name": "Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.",
"datePublished": "2022-09-24",
"url": "https://questionsmedicales.fr/article/36253300",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clgc.2022.09.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Opportunities for prostate-specific membrane antigen hybrid imaging in prostate cancer].",
"datePublished": "2023-09-13",
"url": "https://questionsmedicales.fr/article/37702749",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00120-023-02189-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides aminés",
"item": "https://questionsmedicales.fr/mesh/D000596"
},
{
"@type": "ListItem",
"position": 4,
"name": "Acides aminés essentiels",
"item": "https://questionsmedicales.fr/mesh/D000601"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tryptophane",
"item": "https://questionsmedicales.fr/mesh/D014364"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tryptophane - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tryptophane",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tryptophane",
"description": "Comment diagnostiquer une carence en tryptophane ?\nQuels tests sont utilisés pour évaluer le métabolisme du tryptophane ?\nQuels symptômes indiquent un déficit en tryptophane ?\nLe tryptophane peut-il être mesuré dans l'urine ?\nQuels sont les marqueurs biologiques du tryptophane ?",
"url": "https://questionsmedicales.fr/mesh/D014364?mesh_terms=Prostate-Specific+Antigen#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tryptophane",
"description": "Quels sont les symptômes d'une carence en tryptophane ?\nLe tryptophane affecte-t-il l'humeur ?\nComment le tryptophane influence-t-il le sommeil ?\nDes troubles de l'appétit peuvent-ils être liés au tryptophane ?\nLe tryptophane peut-il causer des maux de tête ?",
"url": "https://questionsmedicales.fr/mesh/D014364?mesh_terms=Prostate-Specific+Antigen#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tryptophane",
"description": "Comment prévenir une carence en tryptophane ?\nLes régimes végétariens sont-ils à risque pour le tryptophane ?\nQuels conseils nutritionnels pour le tryptophane ?\nLe stress affecte-t-il le niveau de tryptophane ?\nLes suppléments préventifs de tryptophane sont-ils recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D014364?mesh_terms=Prostate-Specific+Antigen#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tryptophane",
"description": "Comment traiter une carence en tryptophane ?\nLes antidépresseurs affectent-ils le tryptophane ?\nQuels aliments sont riches en tryptophane ?\nLes suppléments de tryptophane sont-ils sûrs ?\nLe tryptophane peut-il être utilisé pour l'anxiété ?",
"url": "https://questionsmedicales.fr/mesh/D014364?mesh_terms=Prostate-Specific+Antigen#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tryptophane",
"description": "Quelles complications peuvent survenir avec une carence en tryptophane ?\nUne surconsommation de tryptophane peut-elle être dangereuse ?\nLe tryptophane peut-il interagir avec d'autres médicaments ?\nQuels risques psychologiques sont associés à un faible tryptophane ?\nLe tryptophane peut-il affecter la santé cardiovasculaire ?",
"url": "https://questionsmedicales.fr/mesh/D014364?mesh_terms=Prostate-Specific+Antigen#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tryptophane",
"description": "Quels facteurs augmentent le risque de carence en tryptophane ?\nLes personnes âgées sont-elles à risque pour le tryptophane ?\nLe stress chronique influence-t-il le tryptophane ?\nLes troubles alimentaires affectent-ils le tryptophane ?\nLes régimes végétaliens présentent-ils un risque pour le tryptophane ?",
"url": "https://questionsmedicales.fr/mesh/D014364?mesh_terms=Prostate-Specific+Antigen#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une carence en tryptophane ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic peut être établi par des analyses sanguines mesurant les niveaux de tryptophane."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer le métabolisme du tryptophane ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de métabolisme des acides aminés et des dosages de sérotonine peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un déficit en tryptophane ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'anxiété, l'insomnie et la dépression peuvent indiquer un déficit."
}
},
{
"@type": "Question",
"name": "Le tryptophane peut-il être mesuré dans l'urine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tryptophane peut être mesuré dans l'urine pour évaluer son excrétion."
}
},
{
"@type": "Question",
"name": "Quels sont les marqueurs biologiques du tryptophane ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de tryptophane et de sérotonine dans le sang sont des marqueurs clés."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une carence en tryptophane ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, irritabilité, troubles du sommeil et dépression."
}
},
{
"@type": "Question",
"name": "Le tryptophane affecte-t-il l'humeur ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tryptophane est un précurseur de la sérotonine, influençant l'humeur."
}
},
{
"@type": "Question",
"name": "Comment le tryptophane influence-t-il le sommeil ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il favorise la production de mélatonine, régulant ainsi le cycle du sommeil."
}
},
{
"@type": "Question",
"name": "Des troubles de l'appétit peuvent-ils être liés au tryptophane ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une carence peut entraîner des troubles de l'appétit et des envies alimentaires."
}
},
{
"@type": "Question",
"name": "Le tryptophane peut-il causer des maux de tête ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une carence en tryptophane peut contribuer à des maux de tête liés à l'anxiété."
}
},
{
"@type": "Question",
"name": "Comment prévenir une carence en tryptophane ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée incluant des protéines peut prévenir une carence en tryptophane."
}
},
{
"@type": "Question",
"name": "Les régimes végétariens sont-ils à risque pour le tryptophane ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les régimes végétariens peuvent être à risque s'ils manquent de sources de protéines complètes."
}
},
{
"@type": "Question",
"name": "Quels conseils nutritionnels pour le tryptophane ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Inclure des aliments comme les légumineuses, les graines et les produits laitiers dans l'alimentation."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il le niveau de tryptophane ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut réduire la disponibilité du tryptophane dans le corps."
}
},
{
"@type": "Question",
"name": "Les suppléments préventifs de tryptophane sont-ils recommandés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être recommandés, mais il est préférable de consulter un professionnel de santé."
}
},
{
"@type": "Question",
"name": "Comment traiter une carence en tryptophane ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut des suppléments de tryptophane et une alimentation riche en protéines."
}
},
{
"@type": "Question",
"name": "Les antidépresseurs affectent-ils le tryptophane ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains antidépresseurs augmentent la disponibilité du tryptophane dans le cerveau."
}
},
{
"@type": "Question",
"name": "Quels aliments sont riches en tryptophane ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les aliments comme la dinde, le chocolat, les noix et les produits laitiers sont riches en tryptophane."
}
},
{
"@type": "Question",
"name": "Les suppléments de tryptophane sont-ils sûrs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "En général, ils sont sûrs, mais il est conseillé de consulter un médecin avant de commencer."
}
},
{
"@type": "Question",
"name": "Le tryptophane peut-il être utilisé pour l'anxiété ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut aider à réduire l'anxiété en augmentant les niveaux de sérotonine."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une carence en tryptophane ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles de l'humeur, des problèmes de sommeil et des troubles alimentaires."
}
},
{
"@type": "Question",
"name": "Une surconsommation de tryptophane peut-elle être dangereuse ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surconsommation peut entraîner des effets secondaires comme des nausées et des vertiges."
}
},
{
"@type": "Question",
"name": "Le tryptophane peut-il interagir avec d'autres médicaments ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut interagir avec certains antidépresseurs et médicaments pour le sommeil."
}
},
{
"@type": "Question",
"name": "Quels risques psychologiques sont associés à un faible tryptophane ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un faible niveau de tryptophane peut augmenter le risque de dépression et d'anxiété."
}
},
{
"@type": "Question",
"name": "Le tryptophane peut-il affecter la santé cardiovasculaire ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux déséquilibrés de tryptophane peuvent influencer la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de carence en tryptophane ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les régimes pauvres en protéines, le stress et certaines maladies peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles à risque pour le tryptophane ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir un risque accru de carence en raison de l'alimentation."
}
},
{
"@type": "Question",
"name": "Le stress chronique influence-t-il le tryptophane ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut diminuer les niveaux de tryptophane dans le corps."
}
},
{
"@type": "Question",
"name": "Les troubles alimentaires affectent-ils le tryptophane ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles alimentaires peuvent entraîner une carence en tryptophane."
}
},
{
"@type": "Question",
"name": "Les régimes végétaliens présentent-ils un risque pour le tryptophane ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les régimes végétaliens peuvent manquer de sources adéquates de tryptophane."
}
}
]
}
]
}
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.
University of Chinese Academy of Sciences, 19A Yuquan Road, Beijing 100049, China.
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.
University of Chinese Academy of Sciences, 19A Yuquan Road, Beijing 100049, China.
School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, UCAS, Hangzhou 310024, China.
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.
University of Chinese Academy of Sciences, 19A Yuquan Road, Beijing 100049, China.
School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, UCAS, Hangzhou 310024, China.
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.
University of Chinese Academy of Sciences, 19A Yuquan Road, Beijing 100049, China.
School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, UCAS, Hangzhou 310024, China.
Phytochem Lab, Department of Agricultural and Environmental Sciences, Center for Studies on Bioispired Agro-Environmental Technology (BAT Center), National Interuniversity Consortium of Materials Science and Technology, Università degli Studi di Milano, 20133 Milan, Italy.
There is controversy on prostate cancer screening with the prostate-specific antigen (PSA) test in the USA, and as a result, there has been an increased push for physicians to have a thorough discussi...
Approximately 0.4-1.3% of the worldwide population is transgender. Although the exact prevalence is unknown, there is an increase in open identification as transgender. Among transgender women (TW), t...
To assess our current understanding of CaP incidence and prostate-specific antigen (PSA) screening in TW....
We performed a nonsystematic narrative review of all PubMed publications through June 2022 according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) statement. Given ...
There is no consensus regarding PSA screening in TW from any of the major societies, and TW are largely absent from guidelines. Case report data suggest that TW with CaP may have more aggressive disea...
We are in the infancy of our understanding of PSA screening in TW. Important avenues for future research include understanding the risks/benefits of PSA screening in TW, how best to mitigate potential...
We examined patterns of prostate cancer screening for transgender women. Little is known about prostate cancer incidence or screening in this population. Additional research is needed to establish gui...
Prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) is increasingly incorporated in the therapeutic algorithm of patients with metastatic castration-resistant prostate cancer ...
In this bicentric analysis, we included 184 mCRPC patients treated with...
A total of 114/184 patients (62.0%) showed any PSA decline (PSA response >50%, 55/184 [29.9%]). For individuals exhibiting a PSA decline >50%, OS of 19 months was significantly longer relative to nonr...
In mCRPC patients scheduled for RLT, early biochemical response was tightly linked to prolonged survival, irrespective of the magnitude of PSA decline. As such, even in patients with PSA decrease of l...
In this study, it was aimed to investigate the reliability of total prostate-specific antigen (t-PSA) in prostate cancer screening in hyperglycemic (≥126 mg/dL) individuals....
This research was planned as a cross-sectional retrospective study. Three hundred eleven cases which underwent biopsy with the suspicion of prostate cancer in the hospital were included in the study. ...
It was determined that the t-PSA measurement was higher in the patient group with cancer (P < .001). It was determined that the median t-PSA levels of the intermediate and high cancer groups were high...
As a contribution to literature, we found that the t-PSA test lost its sensitivity in cases with plasma glucose levels above normal. Loss of sensitivity may result in underdiagnosis in prostate cancer...
Prostate-specific membrane antigen (PSMA) hybrid imaging is a promising new technique gaining importance in the field of prostate cancer (PCa) diagnosis and treatment planning. By combining PSMA radio...
Prostate-specific antigen (PSA) screening for prostate cancer is controversial but may be associated with benefit for certain high-risk groups....
To evaluate associations of county-level PSA screening prevalence with prostate cancer outcomes, as well as variation by sociodemographic and clinical factors....
This cohort study used data from cancer registries based in 8 US states on Hispanic, non-Hispanic Black, and non-Hispanic White men aged 40 to 99 years who received a diagnosis of prostate cancer betw...
County-level PSA screening prevalence was estimated using the Behavior Risk Factor Surveillance System survey data from 2004, 2006, 2008, 2010, and 2012 and weighted by population characteristics....
Multivariable logistic, Cox proportional hazards regression, and competing risks models were fit to estimate adjusted odds ratios (AOR) and adjusted hazard ratios (AHR) for associations of county-leve...
Of 814 987 men with prostate cancer, the mean (SD) age was 67.3 (9.8) years, 7.8% were Hispanic, 12.2% were non-Hispanic Black, and 80.0% were non-Hispanic White; 17.0% had advanced disease. There wer...
This population-based cohort study of men with prostate cancer suggests that higher county-level prevalence of PSA screening was associated with lower odds of advanced disease, all-cause mortality, an...
The incidence rate of prostate cancer (PCa) has continued to rise in Korea. This study aimed to construct and evaluate a 5-year PCa risk prediction model using a cohort with PSA < 10 ng/mL by incorpor...
The PCa risk prediction model including PSA levels and individual risk factors was constructed using a cohort of 69,319 participants from the Kangbuk Samsung Health Study. 201 registered PCa incidence...
The risk prediction model included age, smoking status, alcohol consumption, family history of PCa, past medical history of dyslipidemia, cholesterol levels, and PSA level. Especially, an elevated PSA...
Our risk prediction model was effective in predicting PCa in a population according to PSA levels. When PSA levels are inconclusive, an assessment of both PSA and specific individual risk factors (e.g...
For metastatic hormone naïve prostate cancer patients, androgen deprivation therapy (ADT) with escalation therapy including docetaxel and/or androgen targeting drugs is the standard therapy. However, ...
Prostate biopsies from 92 patients with metastatic hormone naïve PC (PSA > 80 ng/mL or clinical metastases) were immunohistochemically evaluated for PSA and Ki67. Gene expression analysis was performe...
The immunohistochemical score for PSA was the strongest prognostic factor for progression-free and overall survival after ADT. Consequently, the ratio between Ki67 and PSA displayed a stronger prognos...
PSA and Ki67 immunoreactive scores are prognostic in the metastatic hormone-sensitive setting, with PSA being superior. The combination of Ki67 and PSA did not give additional prognostic value. The re...
To investigate the value of serum free prostate-specific antigen density (fPSAD) in the diagnosis of prostate cancer (PCa)....
The data of 558 patients who underwent transrectal ultrasound-guided prostate biopsy were retrospectively analyzed. According to the pathological results, the patients were divided into a PCa group an...
tPSA, PSAD, (f/t)/PSAD, and fPSAD had high accuracy in predicting PCa with AUC values of 0.820, 0.900, 0.846, and 0.867. fPSAD showed lower diagnostic sensitivity but significantly higher specificity ...
With the optimal cutoff value of 0.062, fPSAD has a higher diagnostic value for PCa than tPSA, f/tPSA, (f/t)/PSAD, and PSAD, and can well predict the risk of PCa, significantly improve the clinical di...
Benign prostatic hyperplasia (BPH) is the most common cause of bladder outlet obstruction in men over the age of 50 years. An association between the prostate specific antigen (PSA), International Pro...
To determine the correlation between the PSA, IPSS and PV in men of African descent....
This was a cross sectional analysis involving 92 patients diagnosed as having symptomatic BPH at the Ho Teaching Hospital....
The data were collected using standardised questionnaires. The IPSS determined urinary symptom severity. The PV was determined using a transabdominal ultrasound machine. Serum PSA was retrieved from t...
The mean PV was 61.04 cm3 ± 21.95 cm3, the mean PSA was 4.21 ng/mL ± 3.85 ng/mL, and mean IPSS of 21.59 ± 3.78. The Pearson's correlation between PV and PSA was 0.283 (p = 0.01), between PV and IPSS w...
This study showed that serum PSA has a positive correlation with PV. However, IPSS had no significant association with PSA or PV in patients with BPH.Contribution: This study provides insights into th...
